Patent: 10,045,943
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,045,943
Title: | Implantable medical devices for extended release of therapeutic agents |
Abstract: | The invention pertains to implantable medical devices for controlled delivery of therapeutic agents. Some devices according to the invention have a titanium reservoir, and a porous titanium oxide based membrane to control the rate of release of the therapeutic agent. The reservoir contains a formulation of the active agent, including a stabilizer for the active agent, wherein the stabilizer is provided in an extended release configuration. |
Inventor(s): | Roorda; Wouter Erik (Emeryville, CA) |
Assignee: | Nano Precision Medical, Inc. (Emeryville, CA) |
Application Number: | 15/094,936 |
Patent Claims: | see list of patent claims |
Details for Patent 10,045,943
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 06/23/1987 | ⤷ Try a Trial | 2034-11-02 |
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 10/16/1986 | ⤷ Try a Trial | 2034-11-02 |
Eli Lilly And Company | HUMATROPE | somatropin | For Injection | 019640 | 02/04/1999 | ⤷ Try a Trial | 2034-11-02 |
Emd Serono, Inc. | SAIZEN | somatropin | For Injection | 019764 | 10/08/1996 | ⤷ Try a Trial | 2034-11-02 |
Emd Serono, Inc. | SAIZEN | somatropin | For Injection | 019764 | 08/29/2000 | ⤷ Try a Trial | 2034-11-02 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |